BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27884222)

  • 1. A Reassessment of the Pathophysiology of Progressive Cardiorenal Disorders.
    Re RN
    Med Clin North Am; 2017 Jan; 101(1):103-115. PubMed ID: 27884222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Expanded View of Progressive Cardiorenal Disorders.
    Re RN
    Am J Med Sci; 2016 Jun; 351(6):626-33. PubMed ID: 27238929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiorenal Syndrome Revisited.
    Zannad F; Rossignol P
    Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?
    Sexton DJ
    Circ Heart Fail; 2014 May; 7(3):536. PubMed ID: 24847129
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy.
    Rincon-Choles H; Kasinath BS; Gorin Y; Abboud HE
    Kidney Int Suppl; 2002 Dec; (82):S8-11. PubMed ID: 12410848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Networking between systemic angiotensin II and cardiac mineralocorticoid receptors.
    Montezano AC; Touyz RM
    Hypertension; 2008 Dec; 52(6):1016-8. PubMed ID: 18981322
    [No Abstract]   [Full Text] [Related]  

  • 8. A possible mechanism for the progression of chronic renal disease and congestive heart failure.
    Re RN
    J Am Soc Hypertens; 2015 Jan; 9(1):54-63. PubMed ID: 25539896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism for mineralocortcoid participation in renal disease and heart failure.
    Re RN
    J Am Soc Hypertens; 2015 Aug; 9(8):586-91. PubMed ID: 26101172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorenal syndrome: an evolutionary point of view.
    Ito S
    Hypertension; 2012 Sep; 60(3):589-95. PubMed ID: 22753218
    [No Abstract]   [Full Text] [Related]  

  • 11. Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
    Vemulapalli S; Tyson CC; Svetkey LP
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):489-99. PubMed ID: 25443574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
    Jing F; Mogi M; Horiuchi M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):23-8. PubMed ID: 22465098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Mehta RL; Rabb H; Shaw AD; Singbartl K; Ronco C; McCullough PA; Kellum JA
    Contrib Nephrol; 2013; 182():174-94. PubMed ID: 23689662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorenal syndrome.
    Ronco C; Di Lullo L
    Heart Fail Clin; 2014 Apr; 10(2):251-80. PubMed ID: 24656104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Organ damage and cardiorenal syndrome in acute heart failure].
    Casado Cerrada J; Pérez Calvo JI
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():26-31. PubMed ID: 24930080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells.
    Zhuo JL; Li XC
    J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):23-33. PubMed ID: 17487823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms.
    Fu Y; Vallon V
    Nephron Physiol; 2014; 128(1-2):8-16. PubMed ID: 25376899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
    Fu Q; Cao L; Li H; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Approach to the Acute Cardiorenal Syndrome.
    Jentzer JC; Chawla LS
    Crit Care Clin; 2015 Oct; 31(4):685-703. PubMed ID: 26410138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.